U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
130951130951Observational Study on Levemir® in Obese Diabetic PatientsCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2Drug: insulin detemirhttps://ClinicalTrials.gov/show/NCT00849342
130952130952A Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects With Metastatic ErbB2 Positive Breast CancerCompletedNo Results AvailableNeoplasms, Breast|Advanced or Metastatic ErbB2-overexpressing Breast CancerDrug: lapatinib|Drug: lapatinib plus esomeprazolehttps://ClinicalTrials.gov/show/NCT00849329
130953130953Safety and Efficacy Study of NovoRapidâ„¢ in Patients With Coexisting Diabetes and Kidney DiseaseWithdrawnNo Results AvailableDiabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2|Chronic Kidney DiseaseDrug: insulin asparthttps://ClinicalTrials.gov/show/NCT00849316
130954130954Multicenter Rehabilitation Study in Acute StrokeRecruitingNo Results AvailableStrokeOther: gait-oriented rehabilitation|Other: gait-oriented rehabilitationhttps://ClinicalTrials.gov/show/NCT00849303
130955130955Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)CompletedHas ResultsMetastatic Androgen Independent Prostate CancerBiological: APC8015Fhttps://ClinicalTrials.gov/show/NCT00849290
130956130956Study of the Effect of Probiotics on Respiratory Morbidity After Influenza Vaccination of Elderly in Nursing HomesCompletedNo Results AvailableRespiratory Tract InfectionsDrug: Lactobacillus casei Shirotahttps://ClinicalTrials.gov/show/NCT00849277
130957130957Comprehensive Treatment for Different Types of Tumor Thrombi in the Portal Vein for Hepatocellular Carcinoma PatientsActive, not recruitingNo Results AvailableHepatocellular Carcinoma|Portal Vein Tumor ThrombusDrug: chemotherapy with endostar|Drug: treatment with CBP and 5-FU|Drug: treatment with endostar, CBP and 5-FUhttps://ClinicalTrials.gov/show/NCT00849264
130958130958Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple MyelomaTerminatedNo Results AvailableRefractory Multiple Myeloma|Stage I Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: cyclophosphamide|Drug: pegylated liposomal doxorubicin hydrochloride|Drug: bortezomib|Drug: dexamethasonehttps://ClinicalTrials.gov/show/NCT00849251
130959130959Mycophenolate Mofetil Maintenance Therapy for Liver TransplantationWithdrawnNo Results AvailablePrimary Liver TransplantDrug: mycophenolate mofetilhttps://ClinicalTrials.gov/show/NCT00849238
130960130960An add-on Study of E2007 in Patients With Refractory Partial Seizures Uncontrolled With Other Anti-epileptic Drugs (AEDs)CompletedHas ResultsRefractory Partial SeizuresDrug: E2007https://ClinicalTrials.gov/show/NCT00849212
130961130961Cancer Screening and Prevention Program for High Risk WomenRecruitingNo Results AvailableOvarian Cancer|Breast Cancerhttps://ClinicalTrials.gov/show/NCT00849199
130962130962Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney CancerCompletedHas ResultsKidney CancerDrug: sunitinib malate|Procedure: neoadjuvant therapy|Procedure: therapeutic conventional surgeryhttps://ClinicalTrials.gov/show/NCT00849186
130963130963Global Study of Women's HealthCompletedNo Results AvailableEndometriosis|Infertility|Chronic Pelvic Pain|Tubal Ligationhttps://ClinicalTrials.gov/show/NCT00849173
130964130964Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.CompletedNo Results AvailableHIV-1 Infection|HIV InfectionsDrug: darunavirhttps://ClinicalTrials.gov/show/NCT00849160
130965130965Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)CompletedHas ResultsPrecursor B-Cell Lymphoblastic Leukemia-Lymphoma|Leukemia, Myeloid, Acute|Burkitt Lymphoma|Lymphoma, B-Cell|Lymphoma, Follicular|Lymphoma, Large B-Cell, DiffuseBiological: Haploidentical Bone Marrow Transplantation|Biological: GVHD prophylaxishttps://ClinicalTrials.gov/show/NCT00849147
130966130966First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160.CompletedNo Results AvailablePain, Inflammatory|PainDrug: GSK1482160 or placebohttps://ClinicalTrials.gov/show/NCT00849134
130967130967Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate CancerActive, not recruitingHas ResultsProstate CancerBiological: pTVG-HP with rhGM-CSF|Biological: pTVG-HP with rhGM-CSFhttps://ClinicalTrials.gov/show/NCT00849121
130968130968Development of 1-Day Rest/Stress Cardiac PET Perfusion Imaging Protocol of BMS747158CompletedHas ResultsIschemiaDrug: BMS747158https://ClinicalTrials.gov/show/NCT00849108
130969130969Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate AsthmaCompletedNo Results AvailableAsthmaDrug: budesonide/formoterol combination (PRN)|Drug: budesonide/formoterol combination|Drug: placebo|Drug: terbutalinehttps://ClinicalTrials.gov/show/NCT00849095
130970130970Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate CancerCompletedNo Results AvailableProstate CancerDrug: cyproterone acetate|Drug: goserelin acetate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00849082
130971130971Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate VaccineTerminatedNo Results AvailableHaemophilus Influenzae|Streptococcus PneumoniaeBiological: GSK2231395A|Biological: TwinrixTMhttps://ClinicalTrials.gov/show/NCT00849069
130972130972Safety and Efficacy of Albiglutide in Type 2 DiabetesCompletedHas ResultsDiabetes Mellitus, Type 2Biological: albiglutide|Drug: placebohttps://ClinicalTrials.gov/show/NCT00849056
130973130973Extension Study of Original Protocol AERO C009 for Obstructive Sleep Apnea-hypopneaCompletedNo Results AvailableObstructive Sleep Apnea Hypopnea|Obstructive Sleep Apnea|OSAHhttps://ClinicalTrials.gov/show/NCT00849043
130974130974ATAC - Arimidex, Tamoxifen Alone or in CombinationCompletedNo Results AvailableBreast CancerDrug: Anastozole (Arimidex)|Drug: Tamoxifen (Nolvadex)|Drug: Anastozole (Arimidex) placebo|Drug: Tamoxifen (Nolvadex) placebohttps://ClinicalTrials.gov/show/NCT00849030
130975130975Safety and Efficacy Study of Albiglutide in Type 2 DiabetesCompletedHas ResultsDiabetes Mellitus, Type 2Biological: albiglutide|Biological: albiglutide uptitration|Biological: placebohttps://ClinicalTrials.gov/show/NCT00849017
130976130976Prevention of Hypertrophic Scars or KeloidsActive, not recruitingNo Results AvailableHypertrophic ScarsOther: silicone gel|Other: silicone sheet|Other: paper tapehttps://ClinicalTrials.gov/show/NCT00849004
130977130977Comparison of Propofol to Precedex With Propofol for Emergence and Recovery in Patients Having Craniotomy SurgeryCompletedNo Results AvailableCranitomy SurgeryDrug: Precedex|Drug: Propofolhttps://ClinicalTrials.gov/show/NCT00848991
130978130978Strength Training in NonagenariansEnrolling by invitationNo Results AvailableElderlyBehavioral: 8-week aerobic and strength training programhttps://ClinicalTrials.gov/show/NCT00848978
130979130979A Randomised, Double Blind, Placebo Controlled, 4 Period, Incomplete Block, Crossover Study Assessing the Dose-response Curve of Fluticasone Propionate in an Antigen Challenge ChamberCompletedHas ResultsRhinitis, Allergic, Perennial|Allergic RhinitisDrug: Fluticasone propionate|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00848965
130980130980Performance of Imaging for the Diagnosis of Small Hepatocellular Carcinoma ( - Not yet recruitingNo Results AvailableHepatocellular CarcinomaOther: 3 imaging techniques are donehttps://ClinicalTrials.gov/show/NCT00848952

* Görseller ve İçerik tekif hakkına sahip olabilir